We Embrace Innovative Approaches to Clinical Development
Our clinical investigation programs focus on innovations that have the potential to deliver highly impactful therapies for serious liver diseases and potentially bring differentiated therapeutic benefits to patients.
ONGOING CLINICAL TRIALS
Phase 2 Study Evaluating BOS-580 in Patients with NAFLD and/or NASH
Status: Active
Study ID #: NCT04880031